Cargando…
Effect of infliximab in sweet’s syndrome-pyoderma gangraenosum overlap syndrome
Autores principales: | Mahler, Birgitte, Glerup, Mia, Steiniche, Torben, Herlin, Troels |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191562/ http://dx.doi.org/10.1186/1546-0096-12-S1-P286 |
Ejemplares similares
-
Generalized pustular psoriasis in infant with heterozygous mutation in the IL36RN gene successfully treated with infliximab
por: Glerup, Mia, et al.
Publicado: (2014) -
Chronic recurrent multifocal osteomyelitis in association with pyoderma gangraenosum
por: Wurm, Matthias Christian, et al.
Publicado: (2016) -
Evaluation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis: A Single Center Experience
por: Høeg, Pia Elkjær, et al.
Publicado: (2022) -
Multilokuläres Pyoderma gangraenosum: Assoziation mit der Erstmanifestation einer primär biliären Cholangitis
por: Kögel, Julian, et al.
Publicado: (2023) -
Successful use of Infliximab in macrophage activation syndrome with severe CNS affection
por: Sellmer, A, et al.
Publicado: (2008)